Abstract 3796: Inhibition of epigenetic chromatin-modification enzymes: histone deacetylases and DNA methyltransferases by silibinin in human NSCLC H1299 cells | Citedby Results | Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Abstract 3796: Inhibition of epigenetic chromatin-modification enzymes: histone deacetylases and DNA methyltransferases by silibinin in human NSCLC H1299 cells

Cancer Res (2010) 70 (8_Supplement): 3796.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Natural bioactive compounds targeting DNA methyltransferase enzymes in cancer: Mechanisms insights and efficiencies

Tarik Aanniz
Abdelhakim Bouyahya
Abdelaali Balahbib
Kawtar El Kadri
Asaad Khalid
Hafiz A. Makeen
Hassan A. Alhazmi
Nasreddine El Omari
Younes Zaid
Rebecca Shin-Yee Wong
Chien Ing Yeo
Bey Hing Goh
Saad Bakrim

Chemico-Biological Interactions (2024) 392: 110907.

The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions

Abdelhakim Bouyahya
Hamza Mechchate
Loubna Oumeslakht
Ikrame Zeouk
Sara Aboulaghras
Abdelaali Balahbib
Gokhan Zengin
Mohammad Amjad Kamal
Monica Gallo
Domenico Montesano
Nasreddine El Omari

Biomolecules (2022) 12 (3): 367.